(As of 5/31/2025)

TD China Income and Growth Fund - F Series

(Greater China Equity)
FundGrade A+® Rating recipient
For more information about FundGrade click here






Inception Return
(9/6/2006) 		5.81 %
YTD Return -3.58 %
NAVPS
(6/23/2025) 		$23.90
Change ($0.04) / -0.17 %
Growth of $10,000 (As of May 31, 2025)
MER 1.27 %
Assets ($mil) $169.54
Rank (1Yr) 37/59
Std Dev (3Yr) 15.48 %
Volatility Ranking (3Yr) 10/10
RRSP Eligibility Yes
Load No Load
Max Front End -
Max Back End -
Sales Status Open
 
Objective
The fundamental investment objective is to seek to earn dividend income and to generate long term capital appreciation by investing primarily in equity securities of issuers located in China. The fundamental investment objective may only be changed with the approval of a majority of unitholders, given at a meeting called for that purpose.
Fund Manager

TD Asset Management Inc.

Portfolio Manager

Dino Vevaina, TD Asset Management Inc.

Sub-Advisor
-
 
Asset Allocation
(As of May 31, 2025)
Sector Allocation
(As of May 31, 2025)
Geographic Allocation
(As of May 31, 2025)
Top 10 Holdings
NameAssetSectorGeographicPercent
Bank of Chengdu Co Ltd Cl AInternational EquityFinancial ServicesAsia/Pacific Rim5.29%
Bank of Jiangsu Co Ltd Cl AInternational EquityFinancial ServicesAsia/Pacific Rim5.23%
China Merchants Bank Co Ltd Cl AInternational EquityFinancial ServicesAsia/Pacific Rim4.69%
Contemporary Amperex Technology Co Ltd - Comn Cl AInternational EquityIndustrial GoodsAsia/Pacific Rim4.39%
Byd Co Ltd Cl AInternational EquityConsumer GoodsAsia/Pacific Rim4.35%
NAURA Technology Group Co Ltd Cl AInternational EquityTechnologyAsia/Pacific Rim4.06%
Zijin Mining Group Co Ltd Cl AInternational EquityBasic MaterialsAsia/Pacific Rim3.75%
Fuyao Glass Industry Group Co Ltd Cl AInternational EquityConsumer GoodsAsia/Pacific Rim3.69%
Ping An Insurance Grp Co of China Ltd - Commn Cl AInternational EquityFinancial ServicesAsia/Pacific Rim3.66%
China Res Sanjiu Medical Pharma Co Ltd - Comn Cl AInternational EquityHealthcareAsia/Pacific Rim3.43%

Performance Data (As of May 31, 2025)
  Return (%) Annualized Return (%)
Return 1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr
Fund 3.04 -3.66 0.49 -3.58 7.79 -1.86 1.48 4.10
Benchmark 2.49 -5.58 -3.24 -3.50 12.09 -0.84 0.95 -4.34
Quartile Ranking 1 2 4 4 3 4 2 1

Calendar Return (%) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Fund 24.43 -16.94 -23.79 9.30 33.59 10.03 -5.61 29.93 2.78 14.37
Benchmark 15.54 -12.56 -21.94 7.65 26.06 25.82 -27.74 5.92 -22.11 39.34
Quartile Ranking 1 4 4 1 2 3 2 4 1 3

Website powered by © Fundata Canada Inc.
Mutual Fund Data provided by Fundata. | View Terms and Conditions of Use.
BofA Merill Lynch Indices used with permission.
© 2025 Fundata Canada Inc. All rights reserved. | View Privacy Policy | Contact Us.